• Login
    View Item 
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Medicine (Sch. of Med.)
    • School of Medicine (Sch. of Med.) Collections
    • View Item
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Medicine (Sch. of Med.)
    • School of Medicine (Sch. of Med.) Collections
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Assessing the association between disclosure of HIV Sero status and contraceptive utilization among HIV positive women at AIDS Information Centre Kampala, Uganda.

    Thumbnail
    View/Open
    Masters Thesis (249.0Kb)
    Date
    2010-12
    Author
    Zalwango, Vivian Winnifred
    Metadata
    Show full item record
    Abstract
    Background Disclosure of HIV sero status is associated with improved sexual behavior. However there is limited information on the association between HIV sero status disclosure and contraceptive utilization among HIV+ women. Objective: To assess the association between disclosure of HIV sero status to the marital partner and contraceptive utilization among HIV positive women Methodology A cross-sectional study was conducted among 373 HIV+ married women of reproductive age receiving HIV care services at AIC, who had tested for HIV status at least 4 weeks prior to the study. These were selected using systematic sampling using AIC post-test club register. Quantitative data was entered using Epi-Info version 3.5.1 and exported to STATA version 10 for analysis. Results: About three quarters (73%) had HIV sero status disclosed to their marital partners in the past six months prior to the study. Reported use of hormonal contraceptives was low (29%), although almost all women were users of condoms for both protection against unwanted pregnancies as well as prevention of re-infection from HIV and STIs. Women who disclosed their HIV sero status where significantly less likely to report use of hormonal contraceptive (adj.PRR=0.58; 0.45 – 0.76) compared to those who did not disclose. Conclusion: The prevalence of HIV sero status disclosure was high. Use of hormonal contraceptive was low, but use of condoms was nearly universal. Disclosure of HIV sero status was associated with lower use of hormonal contraceptive among HIV+ women attending care. Recommendations: Advocacy for disclosure should be increased to raise disclosure prevalence to 100% AIC should sensitize HIV+ women who have disclosed sero status on hormonal contraceptive.
    URI
    http://hdl.handle.net/10570/2187
    Collections
    • School of Medicine (Sch. of Med.) Collections

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of Mak IRCommunities & CollectionsTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy TypeThis CollectionTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV